103 related articles for article (PubMed ID: 20609177)
1. To treat or not to treat renal anemia of chronic kidney disease patients?
Tsubakihara Y
Ther Apher Dial; 2010 Jun; 14(3):235-9. PubMed ID: 20609177
[No Abstract] [Full Text] [Related]
2. [Anemia in chronic renal failure and erythropoietin].
Rosenlöf K
Duodecim; 1995; 111(15):1489-95. PubMed ID: 9244705
[No Abstract] [Full Text] [Related]
3. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and tolerability of epoetin zeta, administered intravenously, for maintenance treatment of renal anemia.
Baldamus C; Krivoshiev S; Wolf-Pflugmann M; Siebert-Weigel M; Koytchev R; Bronn A
Adv Ther; 2008 Nov; 25(11):1215-28. PubMed ID: 18931828
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
[TBL] [Abstract][Full Text] [Related]
6. [How to optimize the concept of the variability of haemoglobin in dialysis patients].
Kessler M
Nephrol Ther; 2008 Dec; 4(7):547-8. PubMed ID: 18809370
[No Abstract] [Full Text] [Related]
7. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
Fishbane S
Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
[TBL] [Abstract][Full Text] [Related]
8. Managing anemia. What do we do now? Views from Canada.
Mendelssohn DC; Muirhead N; Manns BJ
Nephrol News Issues; 2007 Jun; 21(7):55-7. PubMed ID: 17623988
[No Abstract] [Full Text] [Related]
9. Do hemodialysis patients need higher doses of erythropoietin if given intravenously rather than subcutaneously?
McMahon LP
Nat Clin Pract Nephrol; 2006 May; 2(5):246-7. PubMed ID: 16932434
[No Abstract] [Full Text] [Related]
10. [Therapeutic guidelines for renal anemia in Japan].
Naito M; Akiba T
Nihon Rinsho; 2004 Jun; 62 Suppl 6():562-5. PubMed ID: 15250369
[No Abstract] [Full Text] [Related]
11. Epoetin delta is effective for the management of anaemia associated with chronic kidney disease.
Spinowitz BS; Pratt RD;
Curr Med Res Opin; 2006 Dec; 22(12):2507-13. PubMed ID: 17166333
[TBL] [Abstract][Full Text] [Related]
12. The EPO/iron marriage: counseling needed.
Bralow S
Nephrol News Issues; 2007 Jun; 21(7):53, 55. PubMed ID: 17623987
[No Abstract] [Full Text] [Related]
13. [Role of renal anemia in progression of chronic kidney disease].
Racki S; Maleta I
Acta Med Croatica; 2009 Sep; 63 Suppl 1():33-7. PubMed ID: 20235353
[TBL] [Abstract][Full Text] [Related]
14. Introduction to "A road map for intravenous iron and anemia management: preparing for the future".
Coyne DW
Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S1-4. PubMed ID: 19010256
[No Abstract] [Full Text] [Related]
15. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
[No Abstract] [Full Text] [Related]
16. [Case of early pronounced anemia and its effective treatment with human recombinant erythropoietin in a female patient with polycystic kidney in a conservative stage of chronic renal failure].
Alekseeva TB; Nikolaev AIu; Trofimova EI
Ter Arkh; 1999; 71(6):70-1. PubMed ID: 10420463
[No Abstract] [Full Text] [Related]
17. Hemoglobin variability in dialysis patients.
Brimble KS; Clase CM
J Am Soc Nephrol; 2007 Aug; 18(8):2218-20. PubMed ID: 17627931
[No Abstract] [Full Text] [Related]
18. Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management.
Kanbay M; Perazella MA; Kasapoglu B; Koroglu M; Covic A
Blood Purif; 2010; 29(1):1-12. PubMed ID: 19816014
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and its use in renal failure.
Sulková S; Krajhanzl A
EDTNA ERCA J; 1996; 22(1):suppl 1-7; quiz 8. PubMed ID: 10723310
[TBL] [Abstract][Full Text] [Related]
20. Target hemoglobin level for EPO therapy in CKD.
Parfrey PS
Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
[No Abstract] [Full Text] [Related]
[Next] [New Search]